RIVERVEST VENTURE FUND III, L.P. purchased 9.1% of their position (200K shares) of ONKURE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $3.00M — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/13/2021ACC: 0000899243-21-015634
10% Owner
Since Apr 2021
-6.51M
Net shares
Net seller
$3.00M
Total acquired
1
Open market trades
1B · 0S
5
Total transactions
2.13M acquired · 8.64M disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+1.10M
Price / share
—
Trade value
—
% of position
394.1%
4/9/2021
279.34K→1.38M
Common Stock
Indirect
Shares
+829.11K
Price / share
—
Trade value
—
% of position
60.1%
4/9/2021
1.38M→2.21M
Common Stock
Indirect
Shares
+200K
Price / share
$15.00
Trade value
$3M
% of position
9.1%
4/9/2021
2.21M→2.41M
Total
Net shares
+2.13M
Net value
$3M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 4/9/2021 | C · Conversion | +1.10M | — | — | 394.1% | 279.34K | 1.38M |
| Common Stock Indirect | 4/9/2021 | C · Conversion | +829.11K | — | — | 60.1% | 1.38M | 2.21M |
| Common Stock Indirect | 4/9/2021 | P · Purchase | +200K | $15.00 | $3M | 9.1% | 2.21M | 2.41M |
| Total | +2.13M | $3M | ||||||
Derivative Transactions2
Series A Preferred Stock
Indirect
Converts to
Common Stock
1.10M shares
Shares
−4.93M
Strike price
Held after
0.00
Exercisable
—
4/9/2021
Series B Preferred Stock
Indirect
Converts to
Common Stock
829.11K shares
Shares
−3.71M
Strike price
Held after
0.00
Exercisable
—
4/9/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Indirect | Common Stock1.10M shares | 4/9/2021 | C · Conversion | −4.93M | — | 0.00 | |
| Series B Preferred Stock Indirect | Common Stock829.11K shares | 4/9/2021 | C · Conversion | −3.71M | — | 0.00 |